Journal of Lipid Research (Jan 1996)

Abnormal cholesterol biosynthesis in the Smith-Lemli-Opitz syndrome.

  • G Salen,
  • S Shefer,
  • A K Batta,
  • G S Tint,
  • G Xu,
  • A Honda,
  • M Irons,
  • E R Elias

Journal volume & issue
Vol. 37, no. 6
pp. 1169 – 1180

Abstract

Read online

The Smith-Lemli-Opitz syndrome is caused by an inherited defect in 7-dehydrocholesterol-delta7-reductase, the enzyme that catalyzes the last reaction in cholesterol biosynthesis, the conversion of 7-dehydrocholesterol to cholesterol. As a result, deficient cholesterol is produced and the precursor 7-dehydrocholesterol and derivatives (8-dehydrocholesterol and 19-nor-5,7,9(10)-cholestatrien-3 beta-ol) accumulate. Tissues (especially brain) deprived of cholesterol, or because of the deposited sterol precursors and derivatives, develop abnormally and function poorly. Replacement with dietary cholesterol may help correct the biochemical defects and improve symptoms.